Alison Bond

Alison Bond serves as the Director of Global Regulatory and R&D Policy at Amgen since August 2021, focusing on initiatives to advance regulatory environments for innovative therapies. Prior experience includes over a decade at Johnson & Johnson, where Alison held various leadership roles in Global Regulatory Policy & Intelligence, contributing to advocacy efforts and engaging in policy discussions with health authorities. Alison's extensive background in pharmacovigilance includes positions at Quanticate, Amarin Corporation, PAREXEL International, British Biotech, and the University of Oxford, encompassing roles from Director to Senior Scientist. Educational credentials include a PhD in Biochemistry, Immunology, and a BSc in Cellular & Molecular Pathology, both from the University of Bristol.